Nicotine Pouch Advertising and Sales in Australia: A Qualitative Study of Younger People's Experiences
Abstract
Issue addressed: Their position as a target demographic of the tobacco industry means younger people are best placed to provide information on the activities of industry actors in relation to nicotine pouches. Accordingly, we aimed to qualitatively examine younger people's exposure to pouch advertising, from where pouches are being sourced, and any notable retailer practices and industry innovations.
Methods: Australians aged 16-39 years were recruited to participate in one of 12 focus groups held February to April 2025. Groups ranged in size from 6 to 10 participants, with a total of 98 participants in attendance. Data were synthesised using template analysis.
Results: Almost all groups reported being exposed to nicotine pouch advertising, despite such advertising being illegal in Australia. Social media was the most common source of advertising exposure, with TikTok the most frequently cited platform. Participants reported that advertising typically featured attractive influencers portraying pouches as "cool" and describing nicotine as "natural". Tobacconists and convenience stores were key product sources. Few retailer practices were identified, with these broadly relating to product cost and inducements.
Conclusions: Results provide initial insights into the insidiousness of the marketing strategies being adopted to sell nicotine pouches to younger people. SO WHAT?: Findings highlight an urgent need for action that protects younger people from tobacco companies and the…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.